Evidence map›Paper›PMID 33546345›Full record

ArticleMedicines (Basel, Switzerland)2021

Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease.

Jeffrey N Weiss, Steven Levy

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicines (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03011541 (Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II), which is not on this map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03011541 narecruitingnot on this map

Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II

TypeinterventionalSponsorMD Stem CellsRan2016 to 2028Enrolled500ConditionsRetinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa, Stargardt DiseaseArmsArm 1
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Evaluation of mesenchymal stem cells as anFrontiers in cell and developmental biology · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffrey N WeissCoral Ridge Medical Center, 821 Coral Ridge Drive, Coral Springs, FL 33065, USA.
Steven LevyMD Stem Cells, 3 Sylvan Road South, Westport, CT 06880, USA.ORCID 0000-0002-9313-3448

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ABCA4 mutationBMSCbone marrow-derived stem cellshereditary macular degenerationhereditary maculopathyjuvenile macular degenerationmacular degenerationSGDT1Stargardt Diseasestem cells

Identifiers

PMID33546345
PMCPMC7913552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.